Tramiprosate 100mg | ≥98%
CSNpharm
Tramiprosate targets soluble Aβ to decrease amyloid plaque deposition and maintains Aβ in a non-fibrillar form.
More Information Supplier Page
Tramiprosate targets soluble Aβ to decrease amyloid plaque deposition and maintains Aβ in a non-fibrillar form.
More Information Supplier Page
Tramiprosate targets soluble Aβ to decrease amyloid plaque deposition and maintains Aβ in a non-fibrillar form.
More Information Supplier Page
Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.
More Information Supplier Page
Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.
More Information Supplier Page
Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.
More Information Supplier Page
Spectinomycin 2HCl 5H2O used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.
More Information Supplier Page
Efinaconazole is a triazole antifungal used to treat for onychomycosis, as it is a 14 alpha-demethylase inhibitor.
More Information Supplier Page
Efinaconazole is a triazole antifungal used to treat for onychomycosis, as it is a 14 alpha-demethylase inhibitor.
More Information Supplier Page
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4 in cell-free assays.
More Information Supplier Page
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4 in cell-free assays.
More Information Supplier Page